Physician profile
Aaron A Hofmann
NPI 1801986401
$10,709,477.74
in general payments reported to CMS, 2019-2025
8 companies · $7,922 in 2025
The $7,922 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.2M · 2020: $1.1M · 2021: $1.6M · 2022: $1.6M · 2023: $2.6M · 2024: $2.6M · 2025: $7,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5.2M · Travel and Lodging: $7,873 · Food and Beverage: $3,918 · Gift: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,187,959.85 |
| Travel and Lodging | $7,872.69 |
| Food and Beverage | $3,917.86 |
| Gift | $237.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $10,694,372.85 | 2019-2025 | Persona, Mymobility Platform |
| Total Joint Orthopedics, INC. | $14,724.91 | 2019-2025 | |
| Think Surgical, INC. | $207.19 | 2024 | |
| Heraeus Medical, LLC. | $65.10 | 2020 | |
| Haemonetics Corporation | $40.12 | 2020-2021 | |
| Medical Device Business Services, INC. | $27.40 | 2021 | |
| Arthrex, INC. | $26.68 | 2021 | |
| Orthofix Medical, INC. | $13.49 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Hofmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.